Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.

Close

Donate

Myeloma Drug Access Navigator

Over the last 15 years, treatment options for myeloma have increased significantly with the addition of novel, targeted agents and drugs. However, in Canada, availability for these treatments, as well as drug coverage, varies from province to province. The process of finding this information can be confusing and sometimes overwhelming.

To simplify the provincial drug coverage information you need, Myeloma Canada has designed the Myeloma Drug Access Navigator tool.

See, at a glance, the drugs that are available and covered in each province and territory.

If you’re looking for a drug that’s privately funded (through private or group insurance plans), consult your insurance provider for more information.

Alternatively, to search for drug treatments that are available through clinical trials please visit Myeloma Canada’s Clinical Trials page. For drugs available through compassionate access by the manufacturer, talk to your doctor or nurse practitioner for more information, or call Myeloma Canada at 1–888–798–5771.

Next

We’re here to help.

Join our community and sign up for our newsletter.